| 1 |
Vamorolone |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [2] 97, 113 💬 |
| 2 |
Vamorolone 0.25 mg/day/day |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
113 [1] 113 💬 |
| 3 |
Vamorolone 0.25 mg/kg/day |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
113 [1] 113 💬 |
| 4 |
Vamorolone 0.75 mg/day/day |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
113 [1] 113 💬 |
| 5 |
Vamorolone 0.75 mg/kg/day |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
113 [1] 113 💬 |
| 6 |
Vamorolone 2.0 mg/day/day |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
113 [1] 113 💬 |
| 7 |
Vamorolone 2.0 mg/kg/day |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
113 [1] 113 💬 |
| 8 |
Vamorolone 4% suspension for oral dosing |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
| 9 |
Vamorolone 6.0 mg/day/day |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
113 [1] 113 💬 |
| 10 |
Vamorolone 6.0 mg/kg/day |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
113 [1] 113 💬 |